your partner to change dimension

Azulis Capital supports high-potential SMEs providing equity funding to accelerate dimension change and facilitate transition by committing to environmental and social responsibility.

/Le regard d'Azulis

First release (april 2019)

Autonomie et dépendance : quelles solutions ?

Adopter une approche humaine de la dépendance

À l’automne 2019, la ministre des Solidarités et de la Santé Agnès Buzyn doit présenter sur la base de la grande concertation nationale lancée l’année dernière un...
04/11/2019 Read the article

Destia, destiné à l’autonomie

Spécialisé dans les services à la personne et le maintien à domicile des publics fragiles, Destia connaît une croissance à deux chiffres depuis sa création en 2015. Avec 70...
04/11/2019 Read the article

/News

RAPPORT RSE 2018

Azulis Capital publie son rapport RSE 2018. Télécharger le rapport au format PDF dans la rubrique Investisseur Responsable.
02/04/2019 Read more

BIOCLINIC

Le FPCI MMF IV vient de signer sa sortie du groupe BIOCLINIC, acteur majeur dans le domaine de la biologie médicale en Ile-de-France. Fondé en 1995 par Philippe Dabi dont il est toujours président aujourd’hui, le groupe BIOCLINIC a accéléré son...
12/28/2018 Read more

COLLOQUE AGROFINANCE 2018

Le 13ème colloque Agrofinance s’est tenu le 20 novembre à Paris réunissant les industriels de l’agroalimentaire et les professionnels de l’investissement. Cette année, Pierre Jourdain, Président du Directoire d’Azulis Capital, était...
11/20/2018 Read more

/Strategy

focuses on french middle market companies with growth potential

We offer buyout or expansion capital schemes to middle market companies with an enterprise value of €20 million to €120 million, with a priority on companies worth €30-€80 million, that are:
- independent, and most often family-owned companies
- managed by dynamic entrepreneurs
- usually with a leading position in their market segment
- with a proactive business plan, and a hub potential around which to structure other businesses
- willing to engage in measures to promote CSR.

  • We support the management team over a period of four to seven years. Our ambition is to significantly increase the value of the company by improving both its financial and non-financial performance.
  • We ensure that management maintains its managerial autonomy and benefits from profit-sharing incentives. We encourage the development of staff profit-sharing in the company.
  • We provide tailor-made solutions to enhance the company’s development capacity.
  • We place high value on management becoming shareholders in the company.
deploy
mask

/Expertise

supporting entrepreneurial projects with our sector know-how and experience

Health & Human Services

Industry & Business Services

Food & Beverage

Retail & B2B distribution

A dedicated two-member team of professionals studies each deal opportunity using a double-sided approach combining a sector-based assessment with an in-depth financial review.

We invest as lead or co-lead investor in:

  • leveraged buy-out transactions
  • growth financing
  • capital replacement with leverage (owner buy-out) or not
deploy
mask

/Responsible
investor